期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

原发性胆汁性肝硬化Mayo评分与Child分级评估分析 被引量：3

下载PDF
导出
摘要 Child-Pugh分级是目前广泛应用判定终末期重症肝病临床病情及预后的重要分级标准之一。然而,随着医学的进展,此系统逐渐暴露出临床局限性,故此寻求新的与之互补的评分系统是临床亟待解决的问题。Mayo评分系统即为一种新的评分体系,具有客观、连续、相对精确等优势。
作者 邵文革 赵彩彦 王亚东
机构地区 承德县医院内三科 河北医科大学第三医院感染科
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第14期2788-2789,共2页 Chinese Journal of Gerontology
关键词 原发性胆汁性肝硬化 Mayo评分系统 CHILD-PUGH分级
分类号 R575.2 [医药卫生—消化系统]
  • 相关文献

参考文献5

  • 1Heathcote EJ. Management of primary biliary cirrhosis. The American association for the study of liver diseases practice guidelines [J]. Hepatology ,2000 ;31 (4) : 1005-13.
  • 2Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease : an evolution from child to MELD. Mayo End-stage Liver Disease [J]. Hepatology ,2001 ;33 (2) :473-5.
  • 3李琴,王宝恩,贾继东.肝功能分级的演变及特点:从Child到MELD[J].中华肝脏病杂志,2004,12(5):319-320. 被引量：78
  • 4Oellerich M, Burdelski M, Lautz HU, et al. Predictors of one-year pretransplant survival in patients with cirrhosis[J]. Hepatology, 1991 ; 14 ( 6 ) : 1029-34.
  • 5Reisman Y,van Dam GM,Gips CH,et al. Survival probabilities of PughChild-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic model. Euricterus Project Management Group [J]. Hepatogastroenterology, 1997 ;44 (16) :982-9.

二级参考文献10

  • 1Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 1973, 60:646-649.
  • 2Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic value of Child- Turcotte criteria in medically treated cirrhosis. Hepatology,1984, 4: 430-435.
  • 3Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology, 1987, 7: 660-664.
  • 4Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31: 864-871.
  • 5Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis.Hepatology, 1996, 23: 164-176.
  • 6Robert A, Chazouilleres O. Prothrombin time in liver failure: time,ratio, activity percentage or international normalized ratio?Hepatology, 1996, 24: 1392-1394.
  • 7Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from Child to MELD. Hepatology, 2001, 33:473-475.
  • 8McCaughan GW, Strasser SI. To MELD or not to MELD?Hepatology, 2001, 34: 215-216.
  • 9Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut, 2003,52: 134-139.
  • 10Child Ⅲ CG, Turcotte JG. Surgery and Portal Hypertension. In:Child Ⅲ CG, ed. The liver and portal hypertension. Philadelphia:Saunders, 1964. 50.

共引文献77

同被引文献29

  • 1Chao-Jun Hu, Feng-Chun Zhang, Yong-Zhe Li, Xuan Zhang.Primary biliary cirrhosis:What do autoantibodies tell us?[J].World Journal of Gastroenterology,2010,16(29):3616-3629. 被引量：29
  • 2张利方,郑山根,阎有功,付丽萍.58例原发性胆汁性肝硬化患者自身抗体特征分析[J].中国免疫学杂志,2007,23(5):471-473. 被引量：9
  • 3Selmi C, Bow/us C L, Gershwin M E, et al. Primary biliary cir- rhosis [J]. Lancet, 2011, 377(9777):1600-9.
  • 4Miyachi K, Hankins R W, Matsushima H, et al. Profile and clini- cal significance of anti-nuclear envelope antibodies found in pa- tients with primary biliary cirrhosis: a multicenter study [ J]. Au- toimmun, 2003, 20(3):247-54.
  • 5Lindor K D. Primary biliary cirrhosis [J]. Hepatology, 2009, 50 ( 1 ) :291 - 308.
  • 6Dickson E R, Grambsch P M, Fleming T R, et al. Prognosis in primary biliary cirrhosis : model for decision making [ J ]. Hepatolo- gy, 1989, 10(1): 1-7.
  • 7Invernizzi P, Crosignani A, Battezzati P M, et al. Comparison of the clinical features and clinical course of antimitochondrial anti- body-positive and negative primary biliary cirrhosis [J]. Hepatolo- gy, 1997, 25(5):1090-5.
  • 8Muratori P, Muratori L, Fen'aft R, et al. Characterization and clinical impact of antinuelear antibodies in primary biliary cirrhosis [J]. Am J Gastroenterol, 2003, 98(2) :431 -7.
  • 9Nakamura M, Kondo H, Mori T, et al. Anti-gp210 and anti-cen- tromere antibodies are different risk factors for the progression of primary biliary cirrhosis [ J]. Hepatology, 2007, 45 ( 1 ) : 118 - 27.
  • 10Worman H J. Nuclear envelope protein autoantigens in primary biliary cirrhosis [J]. Hepatol Res, 2007, 37(3) :406 -11.

引证文献3

二级引证文献2

中国老年学杂志
2011年 第14期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部